Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Enabling Genomic Technologies and Screening Asia

11 Sep 2014 - 12 Sep 2014 - Singapore, Asia



Bookmark and Share


Select Biosciences South East Asia is delighted to announce that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014. 

We are co-hosting the event with The Genome Institute of Singapore (GIS) at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. 

The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields. The first conference track will cover Enabling Genomic Technologies and we are proud to welcome Dr. Kosuke Yusa as our Keynote Speaker for the meeting. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK.

We are also pleased to welcome both Dr. Ramanuj DasGupta, Group Leader/Senior Investigator, GIS, Cancer Therapeutics & Stratified Oncology, Assoc. Professor, NYU Cancer Institute and Dr. Pauline Ng, Group Leader/Senior Investigator, GIS, Chief Informatics Officer, Polaris. They will be representing our partner, The Genome Institute Singapore (GIS).  

The second track is entitled Screening Asia and we are privileged to have Dr. Alex Matter, M.D., Professor David Virshup and Dr. Litao Zhang, as our Keynote Speakers. 

Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb.

Attending this meeting will give you an excellent opportunity for networking with like-minded peers, helping you to find unique solutions and build long term collaborations. With all delegates having full access to both conference tracks, everyone has the opportunity to develop the specific agenda of their choice. 

Select Biosciences South East Asia is looking forward to welcoming you to this exciting event, and we hope that your experience will be both informative and enjoyable.



Further information
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!